#Giveaway  on last slide

AstraZeneca Buys US Biotech CinCor In $1.8B Deal

Scribbled Arrow

TRENDING GLOBALLY

-: FOLLOW US :-  @theinsaneapp

AstraZeneca announced that it had acquired CinCor Pharma in exchange for an upfront cash consideration of approximately USD 1.8 billion.

-: FOLLOW US :-  @theinsaneapp

AstraZeneca, a biopharmaceutical firm, focuses on the development and commercialization of prescription medicines for oncology and rare diseases.

-: FOLLOW US :-  @theinsaneapp

The company said it would offer all CinCor shares at USD26 each to tender buyers.

-: FOLLOW US :-  @theinsaneapp

Additionally, there is a USD10 per-share non-tradeable contingent worth right.

-: FOLLOW US :-  @theinsaneapp

AstraZeneca stated that CinCor's acquisition would cost USD 1.8 billion.

-: FOLLOW US :-  @theinsaneapp

AstraZeneca will also acquire CinCor's marketable securities and cash as part of the transaction.

#GIVEAWAY BY INSANE

Do you know that we give away around $250 USd in cash prizes every week?

Let’s grow together!